Bruker Cellular Analysis (CELL) Form 3 Berkeley Lights / Keith Breinlinger ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Breinlinger Keith

(Last) (First) (Middle)

5858 HORTON STREET, SUITE 320

(Street)

EMERYVILLE CA 94608

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
07/16/2020

3. Issuer Name and Ticker or Trading Symbol
Berkeley Lights, Inc. [ BLI ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Chief Technical Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	55,000	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	(1)	02/12/2025	Common Stock	25,000	0.64	D
Stock Option	(1)	02/26/2024	Common Stock	50,000	0.12	D
Stock Option	(1)	03/23/2026	Common Stock	37,500	2.26	D
Stock Option	(1)	06/16/2023	Common Stock	45,000	0.12	D
Stock Option	(2)	10/13/2024	Common Stock	50,000	0.64	D
Stock Option	(3)	02/01/2027	Common Stock	125,000	2.54	D
Stock Option	(4)	11/01/2027	Common Stock	150,000	2.1	D
Stock Option	(5)	02/06/2029	Common Stock	250,000	6.26	D
Stock Option	(6)	03/04/2030	Common Stock	50,000	11.06	D

Explanation of Responses:

1. The Stock option is currently exercisable.

2. The stock option is currently vested with respect to 47,917 shares, and will vest with respect to the remainder of the shares in equal monthly installments until fully vested on August 16, 2020.

3. The stock option is currently vested with respect to 106,771 shares, and will vest with respect to the remainder of the shares in equal monthly installments until fully vested on February 2, 2021.

4. The stock option is currently vested with respect to 100,000 shares, and will vest with respect to the remainder of the shares in equal monthly installments until fully vested on November 2, 2021.

5. The stock option is currently vested with respect to 88,542 shares, and will vest with respect to the remainder of the shares in equal monthly installments until fully vested on February 7, 2023.

6. The stock option is currently vested with respect to 5,208 shares, and will vest with respect to the remainder of the shares in equal monthly installments until fully vested on February 1, 2024.

Remarks:

Exhibit 24 - Power of Attorney.

	/s/ Stuart L. Merkadeau, Attorney-in-fact for Keith J. Breinlinger	07/16/2020
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.